Pesquisa | Biblioteca Virtual em Saúde

1.

Investigation of hormone-receptor interactions by means of fluorescence labeling.

Dandliker, W B; Brawn, R J; Hsu, M L; Brawn, P N; Levin, J; Meyers, C Y; Kolb, V M.

Cancer Res ; 38(11 Pt 2): 4212-24, 1978 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-212190

2.

Biomimicry as a basis for drug discovery.

Kolb, V M.

Prog Drug Res ; 51: 185-217, 1998.

Artigo em Inglês | MEDLINE | ID: mdl-9949862

3.

Study of the syn and anti isomerism of the long-lasting opiate antagonist naloxazone and related compounds.

Kolb, V M; Gober, J R.

Life Sci ; 33 Suppl 1: 419-22, 1983.

Artigo em Inglês | MEDLINE | ID: mdl-6664221

4.

Fluorescent probes for opioid receptors.

Kolb, V M; Koman, A; Terenius, L.

Life Sci ; 33 Suppl 1: 423-6, 1983.

Artigo em Inglês | MEDLINE | ID: mdl-6319896

5.

Effects of the opioid antagonist naltrexone-estrone azine on the luteinizing hormone-releasing hormone induced release of luteinizing hormone from the pituitary glands of ovariectomized rats.

Armeanu, M C; van Dieten, J A; Kolb, V M; Schoemaker, J; de Koning, J.

Life Sci ; 52(15): 1311-8, 1993.

Artigo em Inglês | MEDLINE | ID: mdl-8464327

6.

Estrogenic effects of the new opioid antagonist naltrexone-estrone azine on pituitary luteinizing hormone secretion in ovariectomized rats.

Armeanu, M C; van Dieten, J A; Kolb, V M; Schoemaker, J; de Koning, J.

Life Sci ; 50(13): 913-21, 1992.

Artigo em Inglês | MEDLINE | ID: mdl-1548976

7.

New opiate-receptor model.

Kolb, V M.

J Pharm Sci ; 67(7): 999-1002, 1978 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-207856

8.

Long-range substituent effects in morphine-type agonists and antagonists: a possible explanation for some opiate anomalies.

Kolb, V M.

J Pharm Sci ; 68(10): 1250-4, 1979 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-512854

9.

New insights in the clastic binding hypothesis for opiate-receptor interactions I: Electron-transfer mechanism.

Kolb, V M.

J Pharm Sci ; 73(6): 715-9, 1984 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-6330344

10.

Angular dependence of the interaction energy between the N lone pair of amines and a proton: relevance to drug-receptor systems.

Kolb, V M; Scheiner, S.

J Pharm Sci ; 73(3): 389-92, 1984 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-6325659

11.

New insights in the clastic binding hypothesis for opiate-receptor interactions II: Proton-transfer mechanism.

Kolb, V M; Scheiner, S.

J Pharm Sci ; 73(6): 719-23, 1984 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-6330345

12.

Operation of long-range substituent effects in rigid opiates: protonated and unprotonated oxymorphone.

Darling, S D; Kolb, V M; Mandel, G S; Mandel, N S.

J Pharm Sci ; 71(7): 763-7, 1982 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-6181247

13.

Luteinizing hormone regulators: luteinizing hormone releasing hormone analogs, estrogens, opiates, and estrogen-opiate hybrids.

Kolb, V M.

Prog Drug Res ; 42: 39-52, 1994.

Artigo em Inglês | MEDLINE | ID: mdl-8085012

14.

Novel and unusual nucleosides as drugs.

Kolb, V M.

Prog Drug Res ; 48: 195-232, 1997.

Artigo em Inglês | MEDLINE | ID: mdl-9204688

15.

Opiate receptors: search for new drugs.

Kolb, V M.

Prog Drug Res ; 36: 49-70, 1991.

Artigo em Inglês | MEDLINE | ID: mdl-1652147

16.

Electron-transfer and charge-transfer clastic binding hypotheses for drug-receptor interactions.

Kolb, V M.

Pharm Res ; 4(6): 450-6, 1987 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-3334168

17.

Influence of intramolecular hydrogen bonding on the electronic structure of oxymorphone.

Scheiner, S; Kolb, V M.

Proc Natl Acad Sci U S A ; 77(10): 5602-5, 1980 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-16592884

18.

A novel comprehensive opiate-receptor model.

Kolb, V M; Snyder, J P.

NIDA Res Monogr ; 75: 41-4, 1986.

Artigo em Inglês | MEDLINE | ID: mdl-2828987

19.

A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.

Koman, A; Kolb, V M; Terenius, L.

Pharm Res ; 4(2): 147-9, 1987 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-2855368

20.

Prolonged receptor blockade by opioid receptor probes.

Koman, A; Kolb, V M; Terenius, L.

Pharm Res ; 3(1): 56-60, 1986 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-24271359

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar:

Investigation of hormone-receptor interactions by means of fluorescence labeling.

Biomimicry as a basis for drug discovery.

Study of the syn and anti isomerism of the long-lasting opiate antagonist naloxazone and related compounds.

Fluorescent probes for opioid receptors.

Effects of the opioid antagonist naltrexone-estrone azine on the luteinizing hormone-releasing hormone induced release of luteinizing hormone from the pituitary glands of ovariectomized rats.

Estrogenic effects of the new opioid antagonist naltrexone-estrone azine on pituitary luteinizing hormone secretion in ovariectomized rats.

New opiate-receptor model.

Long-range substituent effects in morphine-type agonists and antagonists: a possible explanation for some opiate anomalies.

New insights in the clastic binding hypothesis for opiate-receptor interactions I: Electron-transfer mechanism.

Angular dependence of the interaction energy between the N lone pair of amines and a proton: relevance to drug-receptor systems.

New insights in the clastic binding hypothesis for opiate-receptor interactions II: Proton-transfer mechanism.

Operation of long-range substituent effects in rigid opiates: protonated and unprotonated oxymorphone.

Luteinizing hormone regulators: luteinizing hormone releasing hormone analogs, estrogens, opiates, and estrogen-opiate hybrids.

Novel and unusual nucleosides as drugs.

Opiate receptors: search for new drugs.

Electron-transfer and charge-transfer clastic binding hypotheses for drug-receptor interactions.

Influence of intramolecular hydrogen bonding on the electronic structure of oxymorphone.

A novel comprehensive opiate-receptor model.

A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.

Prolonged receptor blockade by opioid receptor probes.